Letrozole*
-
API Product :
Letrozole*
-
CEP :
-
-
WCC :
?
-
Therapeutic Use :
Cytostatic Hormone Therapy; Antineoplastics
-
Originator :
Novartis
-
CAS No. :
112809-51-5
-
Trade Name. :
FEMARA
-
Molecular Weight :
285.303 g/mol
-
Molecular Formula :
C17H11N5
Application
This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen.
General Description
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor which is used in the treatment of hormonally-responsive breast cancer after surgery.